How to Save Money on Entyvio in 2026: Coupons, Discounts, and Patient Assistance

Updated:

March 13, 2026

Author:

Peter Daggett

Summarize this blog with AI:

Learn how to save money on Entyvio in 2026. Covers cash prices, copay cards, patient assistance programs, and tips to reduce your out-of-pocket costs.

How to Save Money on Entyvio in 2026: Coupons, Discounts, and Patient Assistance

Entyvio (Vedolizumab) is one of the most effective treatments for moderate to severe ulcerative colitis and Crohn's disease. It's also one of the most expensive. With a cash price approaching $10,000 per IV infusion and $3,500 per subcutaneous pen, the cost of Entyvio without insurance can be overwhelming.

But here's what many patients don't realize: there are multiple programs and strategies that can dramatically reduce — or even eliminate — your out-of-pocket costs. In this guide, we'll walk you through every option available in 2026 to help you save money on Entyvio.

What Does Entyvio Cost Without Insurance?

Let's start with the numbers so you know what you're working with:

  • Entyvio IV Infusion (300 mg vial): Approximately $9,882 per dose (2026 coupon price)
  • Entyvio Pen (108 mg SC injection): Approximately $3,500 per pen (2026 coupon price)
  • Entyvio SC two-pen pack (WAC): $6,239.94

What Does That Add Up To Per Year?

The total annual cost depends on your formulation and dosing schedule:

  • IV infusion: After induction (3 doses in the first 6 weeks), you'll receive infusions every 8 weeks. That's roughly 8 doses in year one and 6-7 doses per year after that. At ~$9,882 per dose, annual IV costs range from $59,000 to $79,000.
  • SC pen: Every 2 weeks means 26 doses per year. At ~$3,500 each, that's approximately $91,000 per year at full price.

These are staggering numbers. But very few patients actually pay anything close to these amounts. Here's how to bring your costs down.

EntyvioConnect: Takeda's Copay and Patient Assistance Program

The single most important resource for Entyvio patients is EntyvioConnect, Takeda's official patient support program.

Copay Assistance (Commercially Insured Patients)

If you have commercial (private) health insurance, you may be eligible to pay as little as $0 per dose through the EntyvioConnect copay card. The program covers both IV infusions and SC injections up to a maximum annual benefit amount.

To enroll:

  • Call 1-844-368-9846
  • Visit the Entyvio website
  • Ask your doctor's office to enroll you during your next visit

Who qualifies: Patients with commercial insurance (employer plans, marketplace plans, individual plans). The FEHB (Federal Employees Health Benefit) program is also eligible.

Who does NOT qualify: Patients on Medicare, Medicaid, TRICARE, VA, or other government-funded healthcare programs cannot use the copay card.

Patient Assistance Program (Uninsured or Coverage-Denied)

If you don't have insurance or your insurance doesn't cover Entyvio, Takeda's Patient Assistance Program may provide Entyvio at no cost. This is a separate program from the copay card and is based on financial need.

To apply:

  • Call EntyvioConnect at 1-844-368-9846
  • Your doctor's office may need to submit documentation on your behalf
  • Approval is typically based on income and insurance status

Coupons and Discount Cards

If you don't qualify for EntyvioConnect or need additional savings, several coupon and discount card programs may help:

GoodRx

GoodRx occasionally lists coupons for Entyvio, though discounts on specialty biologics are generally modest compared to generic medications. It's worth checking GoodRx for current pricing at specialty pharmacies in your area.

SingleCare

SingleCare may offer discounts on the Entyvio Pen through participating specialty pharmacies. Savings vary by location and pharmacy.

RxSaver and Other Aggregators

Sites like RxSaver, Optum Perks, and BuzzRx aggregate pricing across pharmacies. While savings on specialty biologics are often limited, checking multiple sources can occasionally reveal a better price — especially for the SC formulation.

Important note: Coupon cards and discount programs typically cannot be combined with government insurance (Medicare, Medicaid) or with each other. Always check the terms.

Patient Assistance Programs Beyond Takeda

If you don't qualify for Takeda's program, other organizations may be able to help:

PAN Foundation

The PAN Foundation provides financial assistance for underinsured patients. They periodically open disease-specific funds, including for inflammatory bowel disease. Grants can help cover copays, coinsurance, and deductibles.

Check: panfoundation.org

HealthWell Foundation

Similar to PAN, the HealthWell Foundation offers grants for patients who have insurance but face high out-of-pocket costs. IBD funds may be available depending on the time of year.

Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation offers resources and referrals to financial assistance programs for IBD patients. They maintain an updated list of available programs on their website.

NeedyMeds and RxAssist

Both NeedyMeds.org and RxAssist.org maintain comprehensive databases of patient assistance programs, copay cards, and discount opportunities for hundreds of medications, including Entyvio.

Other Ways to Save on Entyvio

Ask About the SC Pen vs. IV Infusion

Depending on your insurance plan's structure, one formulation may be significantly cheaper for you than the other:

  • IV Entyvio typically processes under your medical benefit, which may have a separate deductible and out-of-pocket maximum
  • SC Entyvio may process under your pharmacy benefit, which may have different (and sometimes more favorable) cost-sharing

Ask your insurance company to compare your estimated costs for each formulation. Your doctor can help you understand whether switching is clinically appropriate.

Maximize Your Insurance Benefits

  • Time your induction strategically: If possible, start Entyvio early in your plan year so that induction costs apply to that year's deductible and out-of-pocket maximum
  • Understand your plan's specialty drug tier: Know what percentage you're responsible for and what your annual maximum is
  • Appeal if necessary: If your insurance denies Entyvio, your doctor can file an appeal. Many denials are overturned on appeal, especially with proper documentation of medical necessity and prior treatment failures

Medicare Patients: Know Your Options

If you're on Medicare:

  • Part B covers IV Entyvio (administered in a clinical setting). You'll pay 20% coinsurance after your deductible ($257 in 2025).
  • Part D may cover SC Entyvio. The 2026 Part D out-of-pocket cap for brand drugs is projected at approximately $2,100.
  • You cannot use Takeda's copay card with Medicare, but you may qualify for the Patient Assistance Program or independent foundations like PAN or HealthWell.
  • Extra Help/LIS (Low-Income Subsidy): If your income is limited, you may qualify for Extra Help, which significantly reduces Part D costs.

Check If Your State Has Additional Programs

Some states offer pharmaceutical assistance programs (SPAPs) that can supplement your federal coverage. Check with your state's health department or visit Medicare.gov for a list of programs in your state.

Final Thoughts

Entyvio is expensive at list price, but very few patients should pay full price. Between Takeda's EntyvioConnect program, independent foundations, insurance optimization, and discount tools, there are multiple layers of savings available.

The key is to start early. Don't wait until you get a surprise bill to explore your options. Enroll in EntyvioConnect when you first start treatment, understand your insurance benefits, and keep a list of backup assistance programs in case your situation changes.

For help finding Entyvio in stock at an affordable price, visit Medfinder.

Related articles:

How much does Entyvio cost per month without insurance?

For the IV formulation, each dose costs approximately $9,882 (given every 8 weeks after induction, so roughly $5,000-$10,000 per month on average). For the SC pen, each injection costs approximately $3,500 and is given every 2 weeks, averaging about $7,000 per month. Annual costs without insurance can range from $40,000 to over $90,000.

Can I get Entyvio for free?

Potentially, yes. Takeda's Patient Assistance Program through EntyvioConnect provides Entyvio at no cost to eligible patients who are uninsured or whose insurance does not cover the medication. Call 1-844-368-9846 to apply. Independent foundations like PAN and HealthWell may also help cover costs for underinsured patients.

Does the EntyvioConnect copay card work with Medicare?

No. The EntyvioConnect copay card cannot be used by patients on Medicare, Medicaid, TRICARE, VA, or other government-funded healthcare programs. Medicare patients may qualify for Takeda's Patient Assistance Program or for grants from independent foundations like the PAN Foundation or HealthWell Foundation.

Is the Entyvio Pen cheaper than the IV infusion?

It depends on your insurance. The list price per pen (~$3,500) is lower than the IV vial (~$9,882), but the SC pen is given every 2 weeks vs. every 8 weeks for IV — so total annual costs may be similar or even higher for SC. However, the SC pen may process under your pharmacy benefit, which could have more favorable cost-sharing than the medical benefit that covers IV infusions. Ask your insurer to compare both options.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy